Status:
COMPLETED
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP)
Lead Sponsor:
Retina Foundation of the Southwest
Conditions:
Retinitis Pigmentosa
AMD
Eligibility:
All Genders
10-85 years
Brief Summary
A new fundus-guided microperimeter (MP-3S) has been developed by Nidek, Inc. to track the fundus of the patient and present stimuli in specific anatomically-defined locations. Furthermore, this tracki...
Detailed Description
Despite recent advances in understanding the pathogenesis of retinitis pigmentosa (RP) and age-related macular degeneration (AMD), precise characterization of the disease phenotype remains elusive. In...
Eligibility Criteria
Inclusion
- clear media
- diagnosis of RP or non neovascular AMD
- normal volunteers
Exclusion
- exudative AMD
- other eye diseases that could cause vision loss
- physical ailments that would preclude comfortable testing
- unable to provide informed consent
Key Trial Info
Start Date :
October 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03322930
Start Date
October 1 2017
End Date
March 1 2019
Last Update
December 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Retina Foundation of the Southwest
Dallas, Texas, United States, 75231